Partillion Selected as Finalist for Multiple Awards at SLAS 2022
Partillion Bioscience has been nominated for multiple awards at the upcoming Society for Laboratory Automation and Screening annual meeting. The SLAS annual meeting is the premier conference for lab automation and drug screening.
We were selected as a top 5 finalist for the Ignite Award for promising new and emerging companies. Additionally, our Nanovial product was selected as a top finalist for the best New Product Award.
We will be exhibiting our products at the Innovation AveNEW as part of the meeting in Boston starting February 7th. Please stop by if you will be attending the event and follow us on LinkedIn to be kept updated on our Nanovial products and when they become available for purchase.
About Partillion Bioscience
Partillion Bioscience is venture-backed life science company developing a next generation single-cell analysis platform. Our award winning nanovial technology enables our customers to accelerate therapeutic development to address the most difficult diseases and provide advanced scientific insights. Our reagent-based platform unlocks the ability to screen hundreds of thousands to millions of individual cells based on critical yet difficult to probe functional information all while using common lab equipment.